Our Science

Team at Nova Therapeutics is highly committed to practice challenging science to create credible intellectual property and deliver innovative medicines. In our endeavor to accelerate our science, we believe in strategic partnering and embrace any potential collaboration, including in-licensing of both early, and late stage preclinical and clinical assets.